The Patent Lawyer
NewsThe latest IP news – to join our panel of Patent news correspondents, please contact us
Chris McDonald MP appointed UK minister with responsibility for IP
Chris McDonald MP has been confirmed as the UK minister with responsibility for intellectual property as part of his role as Minister of State for Science, Innovation and Investment. Chris McDonald MP has been confirmed as the new UK minister with responsibility for...
Chris McDonald MP appointed UK minister with responsibility for IP
Chris McDonald MP has been confirmed as the UK minister with responsibility for intellectual property as part of his role as Minister of State for Science, Innovation and Investment. Chris McDonald MP has been confirmed as the new UK minister with responsibility for...
India proposes new patent practice manual as IP Office seeks stakeholder input
India's IP Office has published a new draft patent practice manual incorporating recent legislative, procedural, and technological developments and is inviting stakeholder comments for 30 days. The Office of the Controller General of Patents, Designs and Trade Marks...
Australian court orders withdrawal of patent applications before publication in extraordinary confidentiality ruling
Australia's Federal Court has ordered a former employee and his company to withdraw patent applications, including a PCT application, before publication after finding a serious question that information obtained during his employment had been improperly used. In an...
Data center boom creates new patent battleground around AI infrastructure
A growing cluster of patent disputes is targeting the cooling, thermal-management, and computing technologies underpinning the rapid expansion of AI data centers. The rapid expansion of artificial intelligence infrastructure is creating a growing body of patent...
Delhi High Court holds “algorithms” and “computer program” not patentable
This article discusses an appeal filed by Kroll Information Assurance, LLC (Appellant), against the order of the Controller General of Patents, Designs, and Trademarks (CG). The appeal concerns the refusal of an Indian Patent Application No. 8100/DELNP/2007 for a...
Samsung’s $112M patent verdict: Maxell makes its mark in IP enforcement
In a significant setback for global tech giant Samsung, a Texas federal jury has handed down a USD 111.7 million verdict in favor of Maxell, ruling that Samsung infringed three patents covering user interface technology, multimedia processing, and smart networking....
Optis v. Apple: what the Federal Circuit’s decision means for functional claiming
The Federal Circuit's June 16, 2025, decision in Optis Cellular Technology, LLC v. Apple Inc., 2025 US App. LEXIS 14745 shines a renewed spotlight on a recurring challenge in patent law: functional claiming. Specifically, it reaffirms the court's willingness to apply...
Delhi High Court denies AbbVie’s anti-cMet ADC patent
This article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi High Court against the refusal of their patent application (Application No. 201817047767) for an anti-cMet antibody-drug conjugate by the Assistant...
UPC and EPO diverge on inventive step: lessons from Amgen’s PCSK9 patent battle
In a landmark test of the new Unified Patent Court (UPC), the European patent landscape faces a striking divergence between the UPC and the European Patent Office (EPO) on the issue of inventive step. The dispute centers on Amgen's European patent EP 3 666 797, which...
Therapeutic efficacy is a must for a novel intermediate compound to overcome Section 3(d) objection
In an appeal case between Zeria Pharmaceutical Co. Ltd., v. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) before the Delhi High Court, wherein the appellant - a Japanese Corporation - filed an Indian Patent Application, numbered 3630/DLNP/2011 (the subject...
Should translation requirements apply equally in patent law?
A recent High Court judgment in India highlights a potential procedural fairness question in patent examination regarding English translation standards. While patent applicants face rigorous translation requirements under multiple Patent Rules, with severe...
UPC validates second medical use patent in Sanofi v. Amgen antibody therapeutics ruling, finds non-infringement
The Düsseldorf Local Division of the Unified Patent Court (UPC) has handed down a key decision in UPC CFI 505/2024, affirming the validity of a second medical use patent owned by Regeneron and licensed to Sanofi. The case involved alleged infringement by Amgen’s PCSK9...
Annual Report 2024 of the Boards of Appeal of the European Patent Office
The Annual Report 2024 of the Boards of Appeal of the European Patent Office has been published today. It is available in English, German, and French on the Boards' website. Delivering decisions of the highest quality continued to be a central priority in 2024. As in...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.